Document:

exhibit10-a.htm

    Entrusted
Management Agreement

    

    Among

    

    Yan
Tinghe,

    

    Shandong
Yong Chun Tang Bioengineering Co. Ltd.

    

    and

    

    Shandong
Spring Pharmaceutical Co., Ltd.,

    

    

    Effective
as of April 1, 2008

    

    This Entrusted Management Agreement
(the "Agreement") is entered into on the 4th  day
of April, 2008 in Shandong, China by:

    

    
      	
              Party
      A:

            	
              1.
      Yan Tinghe, a citizen of PRC with ID Card number 210105681115317, who owns
      100% of Shandong Yong Chun Tang Bioengineering Co. Ltd.;
    and

            

    

    

    
      	
               
      

            	
              2.
      Shandong Yong Chun Tang Bioengineering Co. Ltd., an enterprise
      incorporated and existing within the territory of China in accordance with
      the law of the People's Republic of China, the registration number of its
      legal and valid Business License is 370831228000622, and the legal
      registered address is Gucheng West Road Sihe Office, Sishui County,
      Shandong

            

    

    

    and

    

    
      	
              Party
      B:

            	
              Shandong
      Spring Pharmaceutical Co., Ltd. is a wholly-foreign owned enterprise
      registered in Shandong, PRC, the registration number of its legal and
      valid Business License is 0174939,

            

    

    

    Whereas:

    

    1.        Under
this Agreement, Shandong Yong Chun Tang Bioengineering Co. Ltd. and Yan Tinghe
have acted collectively as one party to this Agreement;

    

    2.        Party
A desires to entrust Shandong Yong Chun Tang Bioengineering Co. Ltd. to Party B
to manage its assets and debts;

    

    3.        Party
B agrees to accept such entrustment and to manage Shandong Yong Chun Tang
Bioengineering Co. Ltd. on behalf of Party A.

    

    Therefore, in accordance with laws
and regulations of the People's Republic of China, the Parties agree as follows
after friendly consultation based on the principle of equality and mutual
benefit.

    

    Article
1.                             Entrusted
Management

    

    1.1        Party
A agrees to entrust the management of Shandong Yong Chun Tang Bioengineering Co.
Ltd. to Party B pursuant to the terms and conditions of this Agreement. Party B
agrees to manage Shandong Yong Chun Tang Bioengineering Co. Ltd. in accordance
with the terms and conditions of this Agreement.

    

    1.2        The
term of this Entrusted Management Agreement shall be from April 1, 2008 (the
“Effective Date” of this Agreement) to the earlier of the
following:

    

    
      	
               
      

            	
              (1)

            	
              the
      winding up of Shandong Yong Chun Tang Bioengineering Co. Ltd.,
      or

            

    

    

    
      	
               
      

            	
              (2)

            	
              the
      termination date of this Entrusted Management Agreement to be determined
      by the Parties hereto, or

            

    

    

    
      	
               
      

            	
              (3)

            	
              the
      date on which Party B completes the acquisition of Shandong Yong Chun Tang
      Bioengineering Co. Ltd.

            

    

    

    1.3        During
the entrusted period, Party B shall be fully responsible for the management of
Shandong Yong Chun Tang Bioengineering Co., Ltd. The management service includes
without limitation the following:

    

    (1)   Party B’s rights
with respect to the operation of Shandong Yong Chun Tang Bioengineering Co. Ltd.
shall include the right to appoint and terminate members of the Board of
Directors and the right to hire managerial and administrative personnel
etc.  Party A or its voting proxy shall make a shareholder's
resolution and a board of directors' resolution based on the decision of Party
B's Board of Directors.

    

    (2)        Party
B has the right to manage and control all assets of Party A.  Shandong
Yong Chun Tang Bioengineering Co., Ltd. shall open an entrusted account or
designate an existing account as an entrusted account. Party B has the full
right to decide the use of the funds in the entrusted account. The signer of the
account shall be appointed or confirmed by Party B. All of the funds of Shandong
Yong Chun Tang Bioengineering Co., Ltd. shall be kept in this account, including
but not limited to its existing working capital and purchase price received from
selling its inventory to Party B.  All payments of funds shall be
disbursed through this entrusted account, including but not limited to the
payment of all existing accounts payable and operating expenses, payment of
employees salaries and purchase of assets.  All revenues from its
operation shall be kept in this account.

    

    (3)        Party
B shall have the full right to control and administer the financial affairs and
daily operation of Shandong Yong Chun Tang Bioengineering Co., Ltd., such as
entering into and performance of contracts, and payment of taxes,
etc.

    

    (4)        If
Shandong Yong Chun Tang Bioengineering Co., Ltd. requires additional funds to
maintain its operations, Party B shall provide such additional funds through a
bank loan or other resources and Party A shall provide necessary assistance in
obtaining these funds.

    

    1.4        In
exchange for the services of Party B pursuant to this Entrusted Management
Agreement, Party A shall pay an entrusted management fee to Party
B.   The entrusted management fee shall equal Shandong Yong Chun
Tang Bioengineering Co., Ltd's net profits, being the monthly revenues after
deduction of operating costs, expenses and taxes. If the net profit is zero,
Shandong Yong Chun Tang Bioengineering Co., Ltd. is not required to pay the
entrusted management fee; if Shandong Yong Chun Tang Bioengineering Co., Ltd.
sustains losses, all such losses will be carried over to next month and deducted
from next month's entrusted management fee. Both Parties shall calculate, and
Party A shall pay, the monthly entrusted management fee within 20 days of the
following month.

    

    1.5        Party
B shall assume all operation risks out of the entrusted management of Shandong
Yong Chun Tang Bioengineering Co., Ltd. and bear all losses of Shandong Yong
Chun Tang Bioengineering Co., Ltd.  If Shandong Yong Chun Tang
Bioengineering Co., Ltd. does not have sufficient funds to repay its debts,
Party B is responsible for paying off these debts on behalf of Shandong Yong
Chun Tang Bioengineering Co., Ltd.  If Shandong Yong Chun Tang
Bioengineering Co., Ltd's net assets are lower than its registered capital,
Party B is responsible for funding the deficit.

    

    Article 2.  Rights
and Obligations of the Parties

    

    2.1        During
the term of this Agreement, Party A's rights and obligations
include:

    

    (1)        to
hand over Shandong Yong Chun Tang Bioengineering Co., Ltd. to Party B for
entrusted management as of the effective date of this Agreement and to hand over
all of business materials together with Business License and corporate seal of
Shandong Yong Chun Tang Bioengineering Co., Ltd. to Party B;

    

    (2)        Party
A has no right to make any decision regarding Shandong Yong Chun Tang
Bioengineering Co., Ltd's operations without the consent of Party
B;

    

    (3)        
to have the right to know the business conditions of Shandong Yong Chun Tang
Bioengineering Co., Ltd. at any time and provide proposals;

    

    (4)        to
assist Party B in carrying out the entrusted management according to Party B's
requirement;

    

    (5)        to
perform its obligations pursuant to the Purchase Option and Cooperation
Agreement by and between the Parties, and not to violate the said
agreement;

    

    (6)        not
to interfere with Party B's management over Shandong Yong Chun Tang
Bioengineering Co., Ltd. in any form by making use of shareholder's
power;

    

    (7)        not
to entrust or grant their shareholders' rights in Shandong Yong Chun Tang
Bioengineering Co., Ltd. to a third party other than Party B without Party B's
consent;

    

    (8)        not
to otherwise entrust any third party other than Party B to manage Shandong Yong
Chun Tang Bioengineering Co., Ltd. in any form without Party B's consent;
and

    

    (9)        not
to terminate this Agreement unilaterally with any reason.

    

    2.2        During
the term of this Agreement, Party B's rights and obligations
include:

    

    (1)        to
enjoy independent and full right to manage Shandong Yong Chun Tang
Bioengineering Co., Ltd.;

    

    (2)        to
enjoy the right to dispose of all assets of Shandong Yong Chun Tang
Bioengineering Co., Ltd.;

    

    (3)        to
enjoy profits and bear losses arising from Shandong Yong Chun Tang
Bioengineering Co., Ltd. operations during the period of entrusted
management;

    

    (4)        to
appoint all directors of Shandong Yong Chun Tang Bioengineering Co.,
Ltd.;

    

    (5)        to
appoint general manager, deputy general manager, financial manager and other
senior managerial personnel of Shandong Yong Chun Tang Bioengineering Co.,
Ltd.;

    

    (6)        to
convene shareholders' meetings of Shandong Yong Chun Tang Bioengineering Co.,
Ltd. and sign resolutions of shareholders' meetings; and

    

    (7)        to
enjoy other rights and perform other obligations under the
Agreement.

    

    Article
3.  Representation and Warranties

    

    The Parties hereby make the following
representations and warranties to each other as of the date of this Agreement
that:

    

    (1)        it
has the right to enter into the Agreement and the ability to perform the
same;

    

    (2)        the
execution and delivery of this Agreement by each party have been duly authorized
by all necessary corporate action;

    

    (3)        the
execution of this Agreement by the officer or representative of each party has
been duly authorized;

    

    (4)        each
party has no reasons that will prevent this Agreement from becoming a binding
and effective agreement between both parties after execution;

    

    (5)        the
execution and performance of the obligations under this Agreement will
not:

    

    
      	
               
      

            	
              (a)

            	
              violate
      any provision of the business license, articles of association or other
      similar documents of its own;

            

    

    

    
      	
               
      

            	
              (b)

            	
              violate
      any provision of the laws and regulations of PRC or other governmental or
      regulatory authority or approval;

            

    

    

    
      	
               
      

            	
              (c)

            	
              violate
      or result in a breach of any contract or agreement to which the party is a
      party or by which it is bound.

            

    

    

    Article
4.  Effectiveness

    

    This Agreement shall take effect
after it is duly executed by the authorized representatives of the parties
hereto with seals affixed.

    

    Article
5.  Liability for Breach of Agreement

    

    During the term of this Agreement,
any violation of any provisions herein by either party constitutes breach of
contract and the breaching party shall compensate the non-breaching party for
the loss incurred as a result of this breach.

    

    Article 6.  Force
Majeure

    

    The failure of either party to
perform all or part of the obligations under the Agreement due to force majeure
shall not be deemed as breach of contract. The affected party shall present
promptly valid evidence of such force majeure, and the failure of performance
shall be settled through consultations between the parties hereto.

    

    Article 7. Governing
Law

    

    The conclusion, validity,
interpretation, and performance of this Agreement and the settlement of any
disputes arising out of this Agreement shall be governed by the laws and
regulations of the People's Republic of China.

    

    Article
8.  Settlement of Dispute

    

    Any disputes under the Agreement
shall be settled at first through friendly consultation between the parties
hereto. In case no settlement can be reached through consultation, each party
shall have the right to submit such disputes to China International Economic and
Trade Arbitration Commission. The Place of arbitration is Shandong Province. The
arbitration award shall be final and binding on both parties.

    

    

    

    

    Article
9.  Severability

    

    9.1   Any provision of this
Agreement that is invalid or unenforceable due to the laws and regulations shall
be ineffective without affecting in any way the remaining provisions
hereof.

    

    9.2.  In the event of the
foregoing paragraph, the parties hereto shall prepare supplemental agreement as
soon as possible to replace the invalid provision through friendly
consultation.

    

    Article
10.  Non-waiver of Rights

    

    10.1   Any failure or
delay by any party in exercising its rights under this Agreement shall not
constitute a waiver of such right.

    

    10.2   Any failure of any
party to demand the other party to perform its obligations under this Agreement
shall not be deemed as a waiver of its right to demand the other party to
perform such obligations later.

    

    10.3   If a party excuses
the non-performance by other party of certain provisions under this Agreement,
such excuse shall not be deemed to excuse any future non-performance by the
other party of the same provision.

    

    Article
11.  Non-transferability

    

    Unless otherwise specified under this
Agreement, no party can assign or delegate any of the rights or obligations
under this Agreement to any third party nor can it provide any guarantee to such
third party or carry out other similar activities without the prior written from
the other party.

    

    Article 12.
Miscellaneous

    

    12.1  Any and all taxes arising
from execution and performance of this Agreement and during the course of the
entrusted management and operation shall be borne by the Parties respectively
pursuant to the provisions of laws and regulations.

    

    12.2  This Agreement is executed
by Chinese and English in duplicate, and in case of any conflict the Chinese
version shall prevail. Each of the original Chinese and English versions of this
Agreement shall be executed in 6 copies.  Each party shall hold two
original of each version, and the rest shall be used for governmental
registration or other necessary approval purposes.

    

    12.3  In witness hereof, the
Agreement is duly executed by the parties hereto on the date first written
above.

    

    

    

    IN WITNESS WHEREOF, the parties have
executed this agreement.

    

    Party
A:

    

    /s/ Yan
Tinghe

    Yan
Tinghe

    

    Shandong
Yong Chun Tang Bioengineering Co., Ltd. (official seal)

    

    By: /s/ Yan
Tinghe

    Authorized
representative: Yan Tinghe

    

    Party
B:

    

    Shandong
Spring Pharmaceutical Co., Ltd.  (official seal)

    

    By: /s/ Yan
Tinghe

    Authorized
representative: Yan Tingheexhibit10-b.htm

    PURCHASE
OPTION AND COOPERATION AGREEMENT

    

    Among

    

    Yan
Tinghe,

    

    Shandong
Yong Chun Tang Bioengineering Co. Ltd.

    

    and

    

    Shandong
Spring Pharmaceutical Co., Ltd.,

    

    

    Effective
as of April 1, 2008

    

    This Purchase Option and Cooperation
Agreement ("this Agreement") is entered into in Shandong, People's Republic of
China (the "PRC") on 4th day of
April, 2008 by and among:

    

    
      	
              Party
      A:

            	
              Shandong
      Spring Pharmaceutical Co., Ltd. is a wholly-foreign owned enterprise
      registered in Shandong, PRC, the registration number of its legal and
      valid Business License is 074939,

            

    

    

    
      	
              Party
      B:

            	
              Yan
      Tinghe, a citizen of PRC with ID Card number 210105681115317, who owns
      100% of Shandong Yong Chun Tang Bioengineering Co.
  Ltd.

            

    

    

    
      	
              Party
      C:

            	
              Shandong
      Yong Chun Tang Bioengineering Co. Ltd., an enterprise incorporated and
      existing within the territory of China in accordance with the law of the
      People's Republic of China, the registration number of its legal and valid
      Business License is 370831228000622, and the legal registered address is
      Gucheng West Road Sihe Office, Sishui County,
  Shandong

            

    

    

    WHEREAS,

    

    The Parties hereto wish to grant Party
A the exclusive purchase option to acquire, at any time upon satisfaction of the
requirements under the PRC law, the entire or a portion of Party B's share of
the equity/assets owned by Party C.

    

    NOW AND THEREFORE, in accordance with
the principle of sincere cooperation, mutual benefit and joint development and
after friendly negotiations, the Parties hereby enter into the following
agreements pursuant to the provisions of relevant laws and regulations of the
PRC

    

    ARTICLE
1:   THE GRANT AND EXERCISE OF PURCHASE OPTION

    

    1.1           The
Parties hereto agree that Party A shall be granted an exclusive purchase option
to acquire, at any time upon satisfaction of the requirements under applicable
laws and conditions as agreed in this Agreement (including, without limitation,
as under applicable laws, when Party B ceases to be Party C's director, or Party
B attempts to transfer his share equity in Party C to any person, the entire or
a portion of Party C's share equity owned by Party B, or the entire or portion
of assets owned by Party C. The purchase option granted hereby shall be
irrevocable during the term of this Agreement and may be exercised by Party A or
any eligible entity designated by Party A.

    

    1.2           Party
A may exercise the aforesaid purchase option by delivering a written notice to
Party B or Party C (the "Exercise Notice").

    

    1.3           Within
thirty (30) days of the receipt of the Exercise Notice, Party B or Party C (as
the case may be) shall execute a share/asset transfer contract and other
documents necessary to effect the respective transfer of share equity or assets
with Party A (or any eligible Party designated by Party A).

    

    1.4           When
applicable laws permit the exercise of the purchase option provided hereunder
and Party A elects to exercise such purchase option, Party B and Party C shall
unconditionally assist Party A to obtain all approvals, permits, registrations,
filings and other procedures necessary to effect the transfer of relevant share
equity or assets.

    

    ARTICLE
2:   REPRESENTATIONS AND WARRANTIES

    

    Each party hereto represents to the
other parties that:

    

    2.1           Each
party hereto represents to the other parties that: (1) it has all the necessary
rights, powers and authorizations to enter into this Agreement and perform its
duties and obligations hereunder; and (2) the execution or performance of this
Agreement shall not violate any significant contract or agreement to which it is
a party or by which it or its assets are bounded.

    

    2.2           
Party B represents to Party A that: (1) he is the legally registered shareholder
of party C and has paid Party C the full amount of Party C's registered capital
required under Chinese law; (2) Party B has not created any mortgage, pledge,
secured interests or other form of debt liabilities over the Share Equity; and
(3) Party B has not sold nor will he sell to any third party his Share Equity in
Party C.

    

    ARTICLE
3:   EXERCISE PRICE

    

    3.1           When
it is permitted by applicable laws, Party A (or any eligible Party designated by
Party A) shall have the right to acquire, at any time, all of Party C's assets
or its share equity owned by Party B at a to be determined fair value
price  If Party A (or any eligible Party designated by Party A) elects
to purchase a portion of Party C's share equity or assets, then the exercise
price for such purpose shall be adjusted accordingly based on the percentage of
such share equity or assets to be purchased over the total share equity or
assets. When Party A (or a qualified entity designated by party A) is to acquire
all or a portion of Party C's equity share or assets from Party B pursuant to
this Agreement, Party A has the right to offset any principal amounts Party C
owes Party A  against the purchase price payable to Party B. When
acquiring share equity or assets from Party B or Party C pursuant to this
Agreement, Party A shall pay an actual purchase price based on the purchase
price under applicable Chinese laws or requirements of relevant authorities, if
the purchase price under applicable laws or requirements of relevant authorities
is higher than the purchase price under this Agreement.

    

    3.2           In
satisfaction of all or part of the purchase price payable to Party B, Party A
shall be entitled to deliver shares of the common stock of China YCT
International Group, Inc., if the common stock is listed on the New York Stock
Exchange, the American Stock Exchange or the NASDAQ Stock Market.  Any
shares delivered in payment of the purchase price will be valued at the last
trade price reported on the primary exchange for the shares on the day
immediately preceding the date on which Party A gives written notice to Party C
of the exercise of the option.

    

    ARTICLE
4:  COVENANTS

    

    The Parties further agree as
follows:

    

    4.1           Before
Party A has acquired all the equity/assets of Party C by exercising the purchase
option provided hereunder, Party C shall not:

    

    
      	
               
      

            	
              4.1.1

            	
              sell,
      assign, mortgage or otherwise dispose of, or create any encumbrance on,
      any of its assets, operations or any legal or beneficiary interests with
      respect to its revenues (unless such sale, assignment, mortgage, disposal
      or encumbrance is relating to its daily operation or has been disclosed to
      and agreed by Party A in writing);

            

    

    

    
      	
               
      

            	
              4.1.2

            	
              enter
      into any transaction which may materially affect its assets, liability,
      operation, equity or other legal rights (unless such transaction is
      relating to its daily operation or has been disclosed to and agreed by
      Party A in writing); or

            

    

    

    
      	
               
      

            	 	
              4.1.3

            	
              distribute
      any dividend to its shareholders in any
manner.

            

    

    

    4.2           Before
Party A has acquired all the equity/assets of Party C by exercising the purchase
option provided hereunder, Party B shall not:

    

    
      	
               
      

            	
              4.2.1

            	
              supplement,
      alter or amend the articles of association of Party C in any manner to the
      extent that such supplement, alteration or amendment may have a material
      effect on Party C's assets, liability, operation, equity or other legal
      rights (except for pro rata increase of registered capital mandated by
      applicable laws);

            

    

    

    
      	
               
      

            	
              4.2.2

            	
              cause
      Party C enter into any transaction to the extent such transaction may have
      a material effect on Party C's assets, liability, operation, equity or
      other legal rights (unless such transaction is relating to Party C's daily
      operation or has been disclosed to and agreed by Party A in writing);
      and

            

    

    

    
      	
               
      

            	
              4.2.3

            	
              cause
      Party C's board of directors to adopt any resolution on distributing
      dividends to its shareholders.

            

    

    

    4.3           After
the execution of this Agreement, Party B shall execute and deliver a proxy to
the agents (the “Agents”) to the satisfaction of Party A to grant the Agents all
voting rights as shareholders of Party C, including without limitations the
right to appoint and elect Party C's directors, general manager and other senior
officers in Party C's shareholders meetings. The initial term of such proxies
shall be twenty (20) years, and the initial term shall be renewed automatically
upon expiration of the proxies unless Party A notifies Party B in writing thirty
(30) days prior to the expiry date to terminate the proxies. Such proxies shall
be based on the conditions that the Agents are Chinese citizens employed by
Party A and shall be subject to Party A's consent. Once the Agents cease to be
employed by Party A or Party A delivers a written notice to Party B requesting
the proxies to be terminated, Party B shall revoke the relevant proxy
immediately and grant the same rights as provided in the proxies to other PRC
citizens employed and designed by Party A. The Agents have agreed to act with
due care and diligence in exercising their rights under the proxies and
indemnify and keep the Principals harmless from any loss or damages caused by
any action in connection with exercise of their rights under the proxy (unless
any loss or damage is caused by Party B’s own intentional or material negligent
actions).

    

    4.4           Party
B shall, to the extent permitted by applicable laws, cause Party C's operational
term to be extended to equal the operational term of Party A.

    

    4.5           Party
A shall provide or arrange other parties to provide financings to Party C to the
extent Party C needs such financing to finance its operation. In the event that
Party C is unable to repay such financing due to its losses, Party A shall waive
or cause the relevant parties to waive all recourse against Party C with respect
to such financing.

    

    4.6           To
the extent Party B is subject to any legal or economic liabilities to any
institution or individual other than Party A as a result of performing his
obligations under this Agreement or any other agreements between him and Party
A, Party A shall provide all support necessary to enable Party B to duly perform
his obligations under this Agreement and any other agreements and to hold Party
B harmless against any loss or damage caused by his performance of obligations
under such agreements.

    

    ARTICLE
5:   CONFIDENTIALITY

    

    Each Party shall keep confidential all
the content of this Agreement.  Without the prior consent of all
Parties, no Party shall disclose any content of this Agreement to any other
party or make any public announcements with respect to any content of this
Agreement. Notwithstanding the forgoing provisions of this Article 5, the
following disclosure shall be permitted: (i) disclosure made pursuant to any
applicable laws or any rules of any stock exchange; (ii) disclosure of
information which has become public information other than due to any breach by
the disclosing party; (iii) disclosure to any Party's shareholders, legal
counsel, accountants, financial advisors or other professional advisors, or (iv)
disclosure to any potential purchasers of a Party or its shareholders'
equity/assets, its other investors, debts or equity financing providers,
provided that the receiving party of confidential information has agreed to keep
the relevant information confidential (such disclosure shall be subject to the
consent of Party A in the event that Party A is not the potential
purchaser).

    

    ARTICLE
6:   APPLICABLE LAW AND EVENTS OF DEFAULT

    

    The execution, effectiveness,
interpretation, performance and dispute resolution of this Agreement shall be
governed by the laws of the PRC.

    

    Any violation of any provision hereof,
incomplete performance of any obligation provided hereunder, any
misrepresentation made hereunder, material concealment or omission of any
material fact or failure to perform any covenants provided hereunder by any
Party shall constitute an event of default.  The defaulting Party
shall assume all the legal liabilities pursuant to the applicable
laws.

    

    ARTICLE
7:   DISPUTE RESOLUTION

    

    7.1           Any
dispute arising from the performance of this Agreement shall be first subject to
the Parties' friendly consultations. In the event any dispute cannot be solved
by friendly consultations, the relevant dispute shall be submitted for
arbitration;

    

    7.2           The
arbitration shall be administered by the Shandong branch of China International
Economic and Trade Arbitration Commission in accordance with the then effective
arbitration rules of the Commission.

    

    7.3           The
arbitration award shall be final and binding on the Parties. The costs of the
arbitration (including but not limited to arbitration fee and attorney fee)
shall be borne by the losing party, unless the arbitration award stipulates
otherwise.

    

    ARTICLE
8:   EFFECTIVENESS

    

    This Agreement shall be effective upon
the execution hereof by all Parties hereto and shall remain effective
thereafter.

    

    This Agreement may not be terminated
without the unanimous consent of all the Parties except Party A may, by giving a
thirty (30) days prior notice to the other Parties hereto, terminate this
Agreement.

    

    ARTICLE
9:   AMENDMENT

    

    All Parties hereto shall fulfill their
respective obligations hereunder. No amendment to this Agreement shall be
effective unless such amendment has been agreed by all of the Parties and Party
A and Party C have obtained necessary authorization and approvals with respect
to such amendment.

    

    

    IN WITNESS WHEREOF, the parties have
executed this agreement.

    

    Party
A

    

    Shandong
Spring Pharmaceutical Co., Ltd.  (official seal)

    

    By: /s/ Yan
Tinghe

    Authorized
representative: Yan Tinghe

    

    Party
B

    

    /s/ Yan
Tinghe

    Yan
Tinghe

    

    Party
C:

    

    Shandong
Yong Chun Tang Bioengineering Co., Ltd. (official seal)

    

    By: /s/ Yan
Tinghe

    Authorized
representative: Yan Tinghe

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]